X Bioscience PCL (BKK:XBIO)

X Bioscience PCL Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	74	1,030	732	1,612	3,532	3,296
Market Cap Growth	-91.59%	40.78%	-54.60%	-54.38%	7.16%	777.50%
Enterprise Value	416	1,408	1,116	2,451	3,856	3,420
Last Close Price	0.07	0.86	1.15	3.21	7.03	6.56
PS Ratio	0.36	3.23	2.35	4.68	13.91	7.93
PB Ratio	0.24	1.25	4.00	15.72	5.25	3.48
P/TBV Ratio	0.72	-	-	-	-	186.94
EV/Sales Ratio	2.03	4.41	3.58	7.11	15.18	8.23
Debt / Equity Ratio	1.11	0.43	2.27	4.61	0.70	0.21
Debt / EBITDA Ratio	-	-	-	-	25.74	-
Asset Turnover	0.26	0.30	0.43	0.34	0.20	0.33
Inventory Turnover	25.33	19.39	16.08	7.15	4.58	5.37
Quick Ratio	0.03	0.14	0.13	0.07	0.11	0.37
Current Ratio	1.06	0.25	0.17	0.12	0.22	0.56
Return on Equity (ROE)	-134.53%	-51.88%	-103.40%	-85.26%	-12.32%	-24.81%
Return on Assets (ROA)	-31.02%	-14.58%	-10.46%	-17.52%	-4.83%	-6.49%
Return on Invested Capital (ROIC)	-57.10%	-28.81%	-21.30%	-33.84%	-9.06%	-12.38%
Return on Capital Employed (ROCE)	-106.70%	-25.60%	-38.50%	-116.60%	-11.70%	-11.70%
Earnings Yield	-538.81%	-25.26%	-20.16%	-35.74%	-7.83%	-7.25%
FCF Yield	-100.00%	-7.16%	-18.26%	-18.07%	-6.02%	-2.05%
Buyback Yield / Dilution	-83.32%	-46.88%	-7.78%	-	-19.79%	6.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.